Navigation Links
DarioHealth Raises $4.28 Million Through Private Placement Offerings
Date:8/17/2017

CAESAREA, Israel, August 17, 2017 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health Company with mobile health and big data solutions, announced today that it has signed securities purchase agreements with domestic and non-U.S. investors for the sale of shares of the Company's common stock and shares of the Company's newly designated Series B Convertible Preferred Stock in concurrent private placement offerings. The Company expects to conduct a closing with respect to the offerings on or before August 22, 2017. Current shareholders have executed securities purchase agreements accounting for 54% of the securities to be sold in the offerings.

As a part of these private placement transactions, which totals $4.28 million in the aggregate before expenses and placement agent fees, the Company will issue 483,333 shares of common stock at a price per share of $1.80 and 1,894,446 shares of Series B Convertible Preferred Stock at a price per share of $1.80. The Series B Preferred Stock is convertible into shares of the Company's common stock at a 1:1 ratio and provides for a 6% dividend payable upon the conversion of the preferred shares. The holders of the Series B Preferred Stock will not be entitled to convert such preferred stock into shares of the Company's common stock until the Company obtains stockholder approval for such issuance. The Company has agreed to file a registration statement covering the resale of the shares of common stock sold in the offering, the shares of common stock underlying the Series B Convertible Preferred Stock and the shares of common stock issuable upon the payment of the dividend, within 60 days of closing. 

The private placement was managed by the Company with the assistance of Aegis Capital Corp., which acted as the placement agent for a portion of the offerings.

The securities described herein have not been registered under the Securities Act of 1933, as amended, and may not be sold in the United States absent registration or an applicable exemption from the registration requirements.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About DarioHealth Corp.

DarioHealth Corp. is a leading global digital health company serving tens of thousands of users with dynamic mobile health solutions. We believe people deserve the best tools to manage their treatment, and harnessing big data, we have developed a unique way for our users to analyze and personalize their diabetes management. With our smart diabetes solution, users have direct access to track and monitor all facets of diabetes, without having the disease slow them down. The acclaimed Dario™ Blood Glucose Monitoring System all-in-one blood glucose meter and native smartphone app gives users an unrivaled method for self-diabetes management. DarioHealth is headquartered in Caesarea, Israel with a regional office in Burlington, Massachusetts. For more information, visit http://mydario.investorroom.com/.

Cautionary Note Regarding Forward-Looking Statements

This news release and the statements of representatives and partners of DarioHealth Corp. (the "Company") related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate," or "continue" are intended to identify forward-looking statements. For example, forward-looking statements are used in this press release when the Company discusses the proposed timing of the closing of the offerings. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario™) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

DarioHealth Corporate and Media Contact:
Shmuel Herschberg
Marketing Director
="file://10.86.178.63/Users/leah.st/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/6Z27PZHN/shmuel@mydario.com" rel="nofollow" target="_blank">shmuel@mydario.com 
+1-914-775-5548

DarioHealth Investor Relations Contact:
Hayden IR
Stephen Hart
DRIO@HaydenIR.com 
+1-917-658-7878

 

View original content:http://www.prnewswire.com/news-releases/dariohealth-raises-428-million-through-private-placement-offerings-300505916.html


'/>"/>
SOURCE DarioHealth Corp.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. DarioHealth to Host Second Quarter Conference Call on August 14, 2017
2. DarioHealth to Present at the 7th Annual LD Micro Invitational
3. DarioHealth Lowers Diabetes Healthcare Costs in Canada
4. DarioHealth Corp. Completes $4.5 Million Public Offering of Common Stock
5. DarioHealth Corp. Announces Proposed Public Offering of Common Stock
6. DarioHealth Reports Fourth Quarter and Year End 2016 Results
7. DarioHealth Corp. to Webcast, Live, at VirtualInvestorConferences.com February 2
8. DarioHealth Accelerates U.S. Device Sales and Consumable Strips Growth in Fourth Quarter
9. Enterin Inc. Raises $12.7 Million in Series A Financing
10. Hill-Rom Exceeds Guidance With Strong Fiscal Second Quarter Financial Results And Raises 2017 Full-Year Outlook
11. ZappRx raises $25 million in Series B funding led by Qiming US Healthcare Fund with Participation from SR One and GV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... reviews on the independent review site Consumer Affairs have ... hearing aids, ranking it higher than Miracle Ear ™, Beltone™, ... ... Aids ... that provides high performance, state-of-the-art, German-engineered hearing aids directly to consumers ...
(Date:9/9/2017)... YORK , Sept. 8, 2017 Dealmed ... largest independent supplier of medical equipment, supplies, drugs, vaccines, ... it has entered into an agreement to acquire Vantage ... equipment based in Holtsville, New York ... specializes in supplying new and emerging medical practices, will ...
(Date:9/7/2017)... RANCHO MIRAGE, Calif. , Sept. 7, 2017  For nearly two ... and service in the Assisted Reproduction Insurance industry. Today, New Life Agency ... expensive fertility medications. ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ... ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... ... Corporation recently unveiled the MirixaPro 6.0 platform. As the industry’s leading Medication ... services are delivered. Based on industry research and market feedback, the latest ...
(Date:9/19/2017)... ... 19, 2017 , ... Back Pain Centers of America ... pain with a reputable physician in their area, announces the addition of Allegion ... Nevada Spine Clinic was founded by board-certified spine surgeon, Jaswinder Grover, M.D. ...
(Date:9/19/2017)... , ... September 19, 2017 , ... The ISO 9001 ... help businesses and organizations become more efficient and improve customer satisfaction. ISO 9001:2015 was ... their own QMS, with a deadline of September 2018. , As described ...
(Date:9/19/2017)... (PRWEB) , ... September 19, ... ... MS, DACVIM, a board-certified veterinary oncologist, has agreed to serve as strategic ... SNOAW). Dr. Tripp is founder of the Bridge Animal Referral Center ...
(Date:9/19/2017)... ... September 19, 2017 , ... Ron Norman, CEO of Team Decades, ... of making a distinct rather than generic impression in the job market if one ... a stack of resumes knows that the first impression they give off is not ...
Breaking Medicine News(10 mins):